Article Text

Download PDFPDF
Endoresection of large uveal melanomas: clinical results in a consecutive series of 200 cases
  1. Eva Biewald1,
  2. Hilke Lautner1,
  3. Mete Gök1,
  4. Gerhard Alfons Horstmann2,
  5. Wolfgang Sauerwein3,
  6. Dirk Flühs3,
  7. Norbert Bornfeld1
  1. 1Department of Ophthalmology, University Hospital Essen, Essen, Germany
  2. 2Gamma-Knife Center, Krefeld, Germany
  3. 3Department of Radiation Oncology, University Hospital Essen, Essen, Germany
  1. Correspondence to Dr Eva Biewald, Department of Ophthalmology, University Hospital Essen, Hufelandstrasse 55, Essen 45127, Germany; eva.biewald{at}


Background To report eye salvaging rate, visual acuity (VA), local recurrences, complications and the potential benefit of adjuvant brachytherapy after endoresection of large uveal melanomas.

Methods 200 patients were included in this retrospective study. They were treated from March 1999 to December 2010 with preoperative stereotactic gamma knife radiosurgery followed by endoresection and adjuvant brachytherapy in most cases.

Results A total of 200 patients were included in this study (113 male, 87 female). Mean tumour height was 9.4 mm and the largest basal diameter ranged from 6.3 to 20 mm. The median follow-up time was 32.3 months. In 13.4% the eye was retained with a VA of 20/50 or better, in 33.6% VA was ranging from 20/400 to 20/50 and 53% had a VA of less than 20/400. In almost 90% of the cases the eye was preserved at the final visit. In 15.5% additional major surgery was required. In terms of survival 15.5% of our patients developed liver metastases during follow-up and died. Local tumour recurrence was observed in 10 out of 200 patients (5%) and was mainly treated with enucleation. The use of an adjuvant ruthenium-106 plaque did not lower the recurrence or enucleation rate significantly.

Conclusions Eyes with a large uveal melanoma can be preserved by stereotactic radiotherapy followed by endoresection with the chance to obtain useful vision in approximately half of the cases. Adjuvant brachytherapy has no beneficial effect except a reduction of the frequency for major revision surgery.

  • Choroid
  • Ciliary body
  • Neoplasia
  • Treatment Surgery

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors NB and EB initiated the study and gave substantial contributions to the conception and design of the work. HL gave substantial contributions on acquisition and analysis, all authors were involved in the interpretation of data and were revising it critically for important intellectual content. All authors approved the version to be published and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Linked Articles

  • At a glance
    Keith Barton James Chodosh Jost Jonas